US government report cited non-existent sources, academics say

A US government report on childhood chronic disease is under scrutiny after academics cited as authors of studies within the report claimed the studies were "totally fabricated." The report, released by the Make America Healthy Again Commission under Health Secretary Robert F. Kennedy Jr., cited non-existent sources to support its conclusions regarding contributing factors to chronic illness in children. The Democratic National Committee has criticized the report as using fabricated sources to justify policy priorities, raising concerns about the integrity of the report's findings and the scientific rigor of the department under Kennedy's leadership.

Analysis

A US government report on children's health, released on May 22nd by the Make America Healthy Again Commission under Health Secretary Robert F. Kennedy Jr., is facing significant credibility challenges due to its reliance on fabricated sources. The report, commissioned via an executive order by President Donald Trump to investigate the "childhood chronic disease crisis," identified poor diet, environmental toxins, stress, insufficient physical activity, and "overmedicalisation" as potential contributors. However, multiple academics, including Columbia University's Guohua Li and Katherine Keyes, whose work was purportedly cited, have publicly stated that the studies attributed to them are "totally fabricated" and do not exist. An amended version was issued on May 29th after digital outlet NOTUS identified seven non-existent sources, with White House press secretary Karoline Leavitt attributing the issue to "formatting issues" and asserting the report's substance was not negated. This assertion is contested by the Democratic National Committee, which accused RFK Jr.'s Department of Health and Human Services of using non-existent sources to justify policy priorities and highlighted numerous citation errors. The controversy is amplified by RFK Jr.'s known promotion of debunked vaccine claims and his recent actions as Health Secretary, including significant job cuts and proposed plans for placebo trials for all new vaccines. This situation raises serious concerns about the scientific integrity of government-led health research and the potential for policy decisions to be based on unsubstantiated information, impacting public trust and the operational environment for healthcare and pharmaceutical sectors.

Key Decisions for Investors

• Investors in healthcare, pharmaceutical, and biotech sectors should closely monitor potential shifts in US health policy and regulatory oversight, particularly concerning child health and vaccine development, given the compromised integrity of this key government report and the leadership at the Department of Health and Human Services.
• Heightened scrutiny of statements and data emanating from the Department of Health and Human Services under its current leadership is warranted due to the report's use of fabricated sources, potentially impacting market sentiment towards initiatives or companies aligning with its controversial findings or policy directions.
• Consider potential reputational risks for entities associated with or relying on data from the Make America Healthy Again Commission's report, and assess the broader implications for scientific credibility in government health pronouncements when making investment decisions related to public health initiatives.